title,text,authors,publish_time,url
Vaccines and Therapeutics Against Hantaviruses,", 2018) , it is feasible to repurpose those FDA-approved drugs targeting vasoactive mediators for use as hantaviral infection therapy","Liu, Rongrong; Ma, Hongwei; Shu, Jiayi; Zhang, Qiang; Han, Mingwei; Liu, Ziyu; Jin, Xia; Zhang, Fanglin; Wu, Xingan",2020-01-30,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002362/
New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets,"In the absence of reliable antiviral drugs and vaccines, development of alternative strategies for influenza prophylaxis and therapy is urgently required","Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.; Kompier, Ronald; Goudsmit, Jaap",2010-02-08,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817000/
Monoclonal antibody-based therapies for microbial diseases," Consequently, mAbs are unlikely to successfully compete with antimicrobial drugs against diseases for which cheap effective therapy is available unless a clear superiority is established for the immunoglobulin therapy alone or in combination with conventional antimicrobial therapy
 Although there are numerous antiretroviral drugs available for the treatment of HIV, the availability of effective mAb therapy could complement chemotherapy by slowing the onset of resistance and possibly enhancing therapeutic efficacy","Saylor, Carolyn; Dadachova, Ekaterina; Casadevall, Arturo",2009-12-30,https://doi.org/10.1016/j.vaccine.2009.09.105
